跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 148 条关于
“Fiasp/NovoLog”
全部
148
临床试验
126
药物
6
机构
4
资讯
12
去年
HHS Expands Medicare Price Negotiations with 15 New Drugs Including Ozempic and Trelegy Ellipta
去年
Critical Drug Shortages Persist in US: ADHD Medications, Chemotherapy Drugs, and Insulin Among Most Affected
3个月前
Medicare Drug Price Negotiation Program Takes Effect: 10 Common Drugs See List Price Cuts of 38% to 79% in 2026
3年前
Medicare Names First 10 Drugs for Price Negotiations, Including Major Diabetes and Cancer Therapies
11个月前
Medicare's First Negotiated Drug Prices Launch January 2026, Delivering $1.5 Billion in Patient Savings
去年
Major Insulin Manufacturers Agree to $35 Monthly Price Caps in State Settlements
上个月
Meitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan), a Biosimilar to NovoLog
10个月前
HRSA Approves Eight Drug Companies for 340B Rebate Model Pilot Program Starting January 2025
去年
FDA Approves Kirsty as First Interchangeable Rapid-Acting Insulin Aspart Biosimilar
去年
Arecor Receives FDA Approval for Phase 2 Trial of Ultra-Concentrated Insulin AT278 in Automated Delivery Systems
第 1 页,共 2 页
上一页
下一页